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To the Editors
Few treatments in psychiatry were discovered and developed 
based on a previously developed theory. The therapeutic 
effects of the first antidepressant and antipsychotic drugs, 
for example, were serendipitously observed before a theory 
on how they work was described. By contrast, convulsive 
therapy was developed in Budapest by Dr. Lazlo Meduna 
based on facts that led him to foresee its possible clini-
cal utility. His experience and interest in microscopically 
studying glial cells and his clinical psychiatric experience 
led him to describe a reduction in glial density in the 
brains of patients with schizophrenia and a rise of glial 
cells in the brains of patients with epilepsy. Other ideas 
were later added to this initial insight. However, this glial 
reduction was never confirmed in the brains of patients with 
schizophrenia.1 The theory was abandoned; however, the 
treatment has continued in its electric version.
The original medical notes of most of Meduna’s first 
patients were recently recovered, and most of the patients 
(23 out of 26) were re-diagnosed using ICD-10 criteria.2 All 
of the patients were male, as he worked in the male ward. 
According to the new criteria, in addition to three patients with 
“pure” schizophrenia, the sample included individuals 
with catatonic schizophrenia (n = 13), schizoaffective (n = 2), 
bipolar manic (n = 1), bipolar mixed (n = 2), acute and transient 
psychotic (n = 1) and psychotic depressive (n = 1) disorders. 
The remission rates were 27% for schizophrenia and 83% for 
affective disorders. Some of the re-diagnoses as catatonic 
schizophrenia could be of affective origin, as catatonia is now 
widely recognized as a syndrome and affective disorders are 
a common etiology.3 Re-diagnosing catatonic schizophrenics as 
bipolar could explain Meduna’s impressive remission rates and 
confirm the best indication for treatment. On the other hand, 
recent findings implicate glial reduction as the most prominent 
feature in the histopathology of major depression and bipolar 
disorder.4 Glial reductions were found in fronto-limbic brain 
regions, such as the subgenual and supragenual regions of the 
anterior cingulate cortex, and in the dorsolateral prefrontal 
cortex and orbitofrontal cortex. An excess of glucocorticoids 
and deficiencies in neurotrophic and angiogenic factors are the 
most plausible explanations for this reduction.5 Unfortunately, 
we do not have access to the brain slices or the clinical records 
that led Meduna to develop convulsive therapy. Could it be that 
some of Meduna’s first brain slices with schizophrenia belonged 
to individuals with misdiagnosed affective disorders with glial 
reduction? We may never know, but the use of broader diag-
nostic criteria could explain the first findings that led to the 
development of convulsive therapy. The theory may not have 
been wrong after all.
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